From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Oxford Cannabinoid – Are directors lining their pockets ahead of an MBI?

By Tom Winnifrith | Thursday 20 January 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The IPO of Oxford Cannabinoid (OCTP), pumped by the tawdry Mail on Sunday on the, false, supposition that Mr Snoop Doggy Dog was an active investor, was – as I predicted an overvalued POS and those backing it have, in eight months, already lost half their money.  This week it admitted to delays in work on its two lead compounds, not that, even before, either would – if they worked – hit markets till 2027. Its founder chairman will soon step down after a share dealing scandal but is already in Thailand “finding himself”. But it gets worse.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 12:24:41